Dow Up0.51% Nasdaq Up0.24%

Keryx Biopharmaceuticals Inc. (KERX)

-NasdaqCM
15.70 Up 0.17(1.09%) Nov 21, 4:00PM EST
|After Hours : 15.72 Up 0.02 (0.13%) Nov 21, 7:48PM EST
Analyst EstimatesGet Analyst Estimates for:
Earnings EstCurrent Qtr.
Dec 14
Next Qtr.
Mar 15
Current Year
Dec 14
Next Year
Dec 15
Avg. Estimate-0.37-0.31-1.16-0.77
No. of Analysts10.003.0010.0010.00
Low Estimate-0.51-0.43-1.30-1.14
High Estimate-0.25-0.23-1.04-0.43
Year Ago EPS-0.21-0.15-0.58-1.16
Revenue EstCurrent Qtr.
Dec 14
Next Qtr.
Mar 15
Current Year
Dec 14
Next Year
Dec 15
Avg. Estimate1.54M9.73M11.95M76.12M
No. of Analysts1031010
Low EstimateNaN7.62M10.26M36.90M
High Estimate5.11M10.94M15.37M115.10M
Year Ago SalesNaN10.00M7.00M11.95M
Sales Growth (year/est)N/A-2.70%70.70%537.00%
Earnings HistoryDec 13Mar 14Jun 14Sep 14
EPS Est-0.16-0.08-0.25-0.27
EPS Actual-0.21-0.15-0.24-0.38
Difference-0.05-0.070.01-0.11
Surprise %-31.20%-87.50%4.00%-40.70%
EPS TrendsCurrent Qtr.
Dec 14
Next Qtr.
Mar 15
Current Year
Dec 14
Next Year
Dec 15
Current Estimate-0.37-0.31-1.16-0.77
7 Days Ago-0.37-0.31-1.16-0.76
30 Days Ago-0.24-0.14-0.91-0.38
60 Days Ago-0.23-0.10-0.89-0.36
90 Days Ago-0.220.04-0.89-0.13
EPS RevisionsCurrent Qtr.
Dec 14
Next Qtr.
Mar 15
Current Year
Dec 14
Next Year
Dec 15
Up Last 7 Days0000
Up Last 30 Days0000
Down Last 30 Days1401
Down Last 90 DaysN/AN/AN/AN/A
Growth EstKERXIndustrySectorS&P 500
Current Qtr.-76.20%N/A-73.50%19.10%
Next Qtr.-106.70%N/A-36.60%19.20%
This Year-100.00%N/A31.50%8.00%
Next Year33.60%N/A22.00%10.70%
Past 5 Years (per annum)0.00%N/AN/AN/A
Next 5 Years (per annum)30.00%14.19%14.41%9.84%
Price/Earnings (avg. for comparison categories)-13.39-10.644.5120.95
PEG Ratio (avg. for comparison categories)-0.4510.623.622.33
Currency in USD.